NASAL INSTILLATION OF MEDICATED OIL (NASYA) SADBINDU TAILA IN PARKINSON’S DISEASE – A CASE SERIES

Authors

  • Israa Ismail Ahmed Panchakarma Consultant, Darsana Ayurveda Clinic, Kozhikode, Kerala
  • Jigeesh P.P. Professor and H.O.D, Department of Panchakarma, Vaidyaratnam P.S. Varier Ayurveda College, Kottakkalm, Kerala

Keywords:

Parkinsons’s disease (PD), Sadbindu taila, Nasya, Nasal instillation

Abstract

Parkinson’s disease (PD) is the second most common neuro-degenerative disease which affects about 1% of the elderly population worldwide. It is a progressive neuro-degenerative condition with cardinal features like bradykinesia, rigidity, tremor and postural stability. The current mainstay of treatment revolves around the oral administration of levodopa. Even though levodopa provides significant relief from bradykinesia and rigidity, it produces certain side-effects like levodopa induced dyskinesia and fatigue. Ayurveda is most often sought after by patients with a hope of obtaining relief from symptoms or the side effects of conventional medication. Nasya is a unique mode of medicine administration through the nose which is used in the management of a varied spectrum of diseases. Ayurveda considers nose as the gateway to the brain and higher centres. Hence, nasya is used as a treatment mode in PD. This case series is a prospective pre and post-test of the nasal instillation of medicated oil Sadbindu taila in 4 subjects for a period of 7 days. The nasal administration of medicated oil produced significant results in freezing, facial expression, rigidity and postural stability and bradykinesia. This case series contributes to the evidence regarding the utility of panchakarma like Nasya in the treatment of neuro-degenerative conditions.

References

I. Stoker TB, Barker RA. Recent developments in the treatment of Parkinson's Disease. F1000Res. 2020;9:F1000 Faculty Rev-862. Published 2020 Jul 31. doi:10.12688/f1000research.25634.1

II. Kalia LV, Lang AE: Parkinson's disease. Lancet. 2015;386(9996):896–912. 10.1016/S0140-6736(14)61393-3

III. Cotzias GC, van Woert MH, Schiffer LM: Aromatic amino acids and modification of parkinsonism. N Engl J Med. 1967;276(7):374–9. 10.1056/NEJM196702162760703

IV. Kim HJ, Mason S, Foltynie T, et al. : Motor complications in Parkinson's disease: 13-year follow-up of the CamPaIGN cohort. Mov Disord. 2020;35(1):185–90. 10.1002/mds.27882

V. Gourie-Devi, M., M. G. Ramu, and B. S. Venkataram. "Treatment of Parkinson's disease in ‘Ayurveda’(ancient Indian system of medicine): discussion paper." Journal of the Royal Society of Medicine 84.8 (1991): 491-492.

VI. Brahmashankar Mishra ed. BHAIŞAJYARATNĀVALĪ of Shri Govinda Dasji, Vol-III. Choukambha Ssnskrit Bhavan. Varanasi.chap 65.p.323.

VII. Shukla M. et al .Comparative study of efficacy of Mulakadi taila Vasti and Nasya in the management of Kampa vata w.s.r. to Parkinson’s Disease. J. Ayu. Herb Med 2016;2(3).

VIII. Kajaria Divya. Role of Jyotismati taila nasya in the management of Parkinson’s disease. Sch. J. App. Med. Sci, 2013; 1 (5); 372-375.

IX. Shivprasad Sharma, ed. Astanga samgraha of Vridha Vaagbhata Sutrasthana ( Sasilekha, comme,Sanskri. Varanasi: Chowkhamba Sanskrit series office, 2012; p.223. 29/2

X. Bondì ML, Di Gesù R, Craparo EF. Lipid nanoparticles for drug targeting to the brain. Methods Enzymol. 2012;508:229-51. doi: 10.1016/B978-0-12-391860-4.00012-4. PMID: 22449929.

XI. Bellettato, C.M., Scarpa, M. Possible strategies to cross the blood–brain barrier. Ital J Pediatr 44, 131 (2018). https://doi.org/10.1186/s13052-018-0563-0

XII. Yadavji Trikamji , Narayan Ram , ed. Susruta samhita of Susruta Cikitsasthana (Nibandhasamgraha , Dalhana, comme, Sanskrit) Varanasi: Chowkhamba Orientalia, 2014. 31/5; p.507

XIII. Yadavji Trikamji , ed. Caraka samhita of Agnivesa Chikitsasthana ( Ayurveda Deepika, comme, Sanskrit) Varanasi: Chaukhamba Orientalia, 2014.28/227; p.626

XIV. Hari Sadasiva Sastri paraadakara vaidya, ed. Ashtanga Hridaya of Vagbhata Nidanasthana (Sarvangasundara, Aurvedarasayana , comme, Sanskrit) Varanasi: Chaukhambha Orientalia, 2014 .15/6; p.531

XV. Shulman et.al. Parkinsons disease: Genetics and Pathogenesis. Annu. Rev. Pathol. Mech. Dis. 2011. 6: 193-222

XVI. Goldman and Posthuma. Premotor and non motor features of Parkinson’s disease. Curr. Opin. Neurol. 2014 August; 27 (4): 434 – 441. doi:10.1097/WCO.0000000000000112

XVII. Ayyathan DM, Chandrasekaran R, Thiagarajan K. Neuroprotective effect of Tagara, an Ayurvedic drug against methyl mercury induced oxidative stress using rat brain mitochondrial fractions. BMC Complement Altern Med. 2015;15:268. Published 2015 Aug 12. doi:10.1186/s12906-015-0793-2

XVIII. de Oliveria, D.M., Barreto, G., De Andrade, D.V.G. et al. Cytoprotective Effect of Valeriana officinalis Extract on an In Vitro Experimental Model of Parkinson Disease. Neurochem Res 34, 215–220 (2009). https://doi.org/10.1007/s11064-008-9749-y

Additional Files

Published

15-05-2022

How to Cite

Israa Ismail Ahmed, & Jigeesh P.P. (2022). NASAL INSTILLATION OF MEDICATED OIL (NASYA) SADBINDU TAILA IN PARKINSON’S DISEASE – A CASE SERIES. International Education and Research Journal (IERJ), 8(5). Retrieved from http://ierj.in/journal/index.php/ierj/article/view/2479

Issue

Vol. 8 No. 5 (2022): MAY ISSUE, INTERNATIONAL EDUCATION AND RESEARCH JOURNAL

Section

Articles

License

Copyright (c) 2022 International Education and Research Journal (IERJ)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.